Rats were injected with either10 μg/kg of 833c and fresolimumab or 10μg 833c&Freso on day 2 after bleomycin (bleo) exposure. BALf was collected on day 3. (A) Total leukocyte and neutrophils in BALf. (B) Percentage (%) inhibition of leukocyte and neutrophil infiltration. N = 4 rats per group. Scatter graphs of each data point with indicated means ± SD. *P (TIF)</p
<p>(A) Drug treatment regimen with anti-neutrophil antibody (anti-Ly6G). Arrows denote days on which...
(A) Control treatment blood film; (B) 0.178 μg/g LAv treatment blood film; (C) 0.89 μg/g LAv treatme...
<p>Group of rats was exposed or not to FA inhalation (1%, 90 min/day, 3 days) and treated or not wit...
833c&Freso at the indicated doses (μg/kg) was injected iv into rats on the indicated days after bleo...
Rats were treated with 833c&Freso at the indicated doses (μg/kg) by iv injection one hour before (-1...
Two days after bleomycin exposure, rats were treated iv with 833c, 833cX&Freso, 833c&Freso, or freso...
Rats were injected with 833c&Freso at the indicated doses (μg/kg) on day 1 and day 2 (D1&2) after bl...
Biochemical assays were performed on lung samples taken from untreated rats and rats treated as indi...
<p>Rats were made neutropenic by injection of cyclophosphamide (CPA) on Day 0. Beginning on Day 1 an...
Rats were treated with 10 μg/kg 833c&Freso iv on day 2 after bleomycin challenge. Lungs excised on d...
Rats were treated with 10 μg/kg 833c&Freso iv on day 2 post-bleomycin. Lung tissue was harvested on ...
After bleomycin treatment, rats were injected iv with radio-iodinated antibodies 125I-833c&Freso, 12...
<p>Rats were made neutropenic by injection of CPA on Day 0. On Day 1 different groups of rats receiv...
Background. In the pathogenesis of type 1 diabetes mellitus (DM1) and many of its complications, an ...
<p>Group of rats was exposed or not to FA inhalation (1%, 90 min/day, 3 days) and treated or not wit...
<p>(A) Drug treatment regimen with anti-neutrophil antibody (anti-Ly6G). Arrows denote days on which...
(A) Control treatment blood film; (B) 0.178 μg/g LAv treatment blood film; (C) 0.89 μg/g LAv treatme...
<p>Group of rats was exposed or not to FA inhalation (1%, 90 min/day, 3 days) and treated or not wit...
833c&Freso at the indicated doses (μg/kg) was injected iv into rats on the indicated days after bleo...
Rats were treated with 833c&Freso at the indicated doses (μg/kg) by iv injection one hour before (-1...
Two days after bleomycin exposure, rats were treated iv with 833c, 833cX&Freso, 833c&Freso, or freso...
Rats were injected with 833c&Freso at the indicated doses (μg/kg) on day 1 and day 2 (D1&2) after bl...
Biochemical assays were performed on lung samples taken from untreated rats and rats treated as indi...
<p>Rats were made neutropenic by injection of cyclophosphamide (CPA) on Day 0. Beginning on Day 1 an...
Rats were treated with 10 μg/kg 833c&Freso iv on day 2 after bleomycin challenge. Lungs excised on d...
Rats were treated with 10 μg/kg 833c&Freso iv on day 2 post-bleomycin. Lung tissue was harvested on ...
After bleomycin treatment, rats were injected iv with radio-iodinated antibodies 125I-833c&Freso, 12...
<p>Rats were made neutropenic by injection of CPA on Day 0. On Day 1 different groups of rats receiv...
Background. In the pathogenesis of type 1 diabetes mellitus (DM1) and many of its complications, an ...
<p>Group of rats was exposed or not to FA inhalation (1%, 90 min/day, 3 days) and treated or not wit...
<p>(A) Drug treatment regimen with anti-neutrophil antibody (anti-Ly6G). Arrows denote days on which...
(A) Control treatment blood film; (B) 0.178 μg/g LAv treatment blood film; (C) 0.89 μg/g LAv treatme...
<p>Group of rats was exposed or not to FA inhalation (1%, 90 min/day, 3 days) and treated or not wit...